fig5
Figure 5. The OS (A) and RFS (B) in CK19-positive patients that received targeted therapy postoperatively. OS: Overall survival; RFS: recurrence-free survival; CK19: cytokeratin 19.
Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/journal-cancer-metastasis-and-treatment
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
